Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries-Reference-Cited by-同舟云学术

Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries

Published:2018-07-01 Issue:Supplement 1 Volume:32 Page:S5-S20
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Patel Pragna,Rose Charles E.,Collins Pamela Y.,Nuche-Berenguer Bernardo,Sahasrabuddhe Vikrant V.,Peprah Emmanuel,Vorkoper Susan,Pastakia Sonak D.,Rausch Dianne,Levitt Naomi S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference206 articles.

1. The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals;Ray;AIDS,2010

2. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.;Lancet,2008

3. Changes in the risk of death after HIV seroconversion compared with mortality in the general population;Bhaskaran;JAMA,2008

4. AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study;Buchacz;AIDS,2010

5. Uncontrolled viral replication as a risk factor for non-AIDS severe clinical events in HIV-infected patients on long-term antiretroviral therapy: APROCO/COPILOTE (ANRS CO8) cohort study;Ferry;J Acquir Immune Defic Syndr,2009

Cited by 184 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preferences for Hypertension Care in Malawi: A Discrete Choice Experiment Among People Living with Hypertension, With and Without HIV;AIDS and Behavior;2024-09-13

2. Opportunities and challenges for the integration of managing non-communicable diseases within HIV care and treatment services in Tanzania;HIV Research & Clinical Practice;2024-09-05

3. Expanding the food environment framework to include family dynamics: A systematic synthesis of qualitative evidence using HIV as a case study;Global Food Security;2024-09

4. Blood glucose outcomes of anti-retroviral therapy naïve Ugandan people with HIV with pre-diabetes mellitus initiated on dolutegravir for 48 weeks;BMC Infectious Diseases;2024-07-29

5. Experiences and lessons learned from a global research administration capacity building project to support and expand HIV/AIDS research in southwestern Uganda;Discover Health Systems;2024-07-16